Selepressin, a novel selective vasopressin V1A agonist, is an effective substitute for norepinephrine in a phase IIa randomized, placebo-controlled trial in septic shock patients — James A. Russell (2017) | RDL Network
Selepressin, a novel selective vasopressin V1A agonist, is an effective substitute for norepinephrine in a phase IIa randomized, placebo-controlled trial in septic shock patients
Xinrong He, Fuhong Su, Fabio Silvio Taccone, Régent Laporte, Anne Louise Kjølbye, Jing Zhang, Keliang Xie, Mouhamed Djahoum Moussa, Torsten Reinheimer, Jean Louis Vincent
Jordi Rello, Krenn Claus-Georg, Gottfried J. Locker, Ernst Pilger, Christian Madl, Laura Balica, Thierry Dugernier, Pierre‐François Laterre, Herbert Spapen, Pieter Depuydt, Jean Louis Vincent, Lajos Bogár, Zsuzsanna Szabó, Völgyes Barbara, Rafael Máñez, Nahit Çakar, Atilla Ramazanoğlu, Arzu Topeli̇, María Mastruzzo, Jasovich Abel, Christian Remolif, Liliana del Carmen Soria, Max Andresen, Carolina Ruíz, Ildikó Krémer, Zsolt Molnár, Frank von Sonnenburg, Arthur Lyons, Michael Joannidis, Heinz Burgmann, Tobias Welte, Anton Klingler, Romana Hochreiter,
Stefan Knop, María‐Victoria Mateos, Meletios A Dimopoulos, Kenshi Suzuki, Andrzej Jakubowiak, Chantal Doyen, Paulo Lúcio, Zsolt Nagy, Ganna Usenko, Luděk Pour, Mark Cook, Sebastian Grosicki, Andre H Crepaldi, Anna Marina Liberati, Philip Campbell, Tatiana Shelekhova, Sung‐Soo Yoon, Genadi Losava, Tomoaki Fujisaki, Mamta Garg, Jianping Wang,
Ludhmila Abrahão Hajjar, Jean Louis Vincent, Andrew Rhodes, D Annane, F Galas, J Almeida, Suely Pereira Zeferino, Leandro Teixeira Câmara, V. Santos, Janet Pereira, E Osawa, Ethel Leonor Nóia Maciel, Adriano Rogério Baldacin Rodrigues, Jaquelline Maria Jardim, D Blini, Eugenio Pacelli Meireles de Araújo, F Bergamin, Roberto Kalil Filho, José Otávio Costa Auler Júnior
Discussion(0)
No comments yet. Be the first to comment.